For citations:
Martynyuk K.I., Pisarenko S.V. PROLONGATION OF QT INTERVAL DURING CHEMOTHERAPY OF PULMONARY TUBERCULOSIS. Tuberculosis and Lung Diseases. 2018;96(6):66. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-6-66
Fullscreen
Popular articles
Vol 96, No 8 (2018)
No 6 (2015)
Vol 96, No 7 (2018)
Vol 99, No 3 (2021)
Vol 97, No 3 (2019)
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Authors
Keywords
COVID-19
HIV infection
M. tuberculosis
adolescents
anti-tuberculosis drugs
bedaquiline
chemotherapy
children
chronic obstructive pulmonary disease
diagnostics
diaskintest
drug resistance
extrapulmonary tuberculosis
incidence
mortality
multiple drug resistance
multiple drug resistant tuberculosis
pulmonary tuberculosis
surgical treatment
treatment
tuberculosis
4, Dostoevsky St., 127473, Moscow
National Medical Research Center of Phthisiopulmonology and Infectious
Diseases of the Ministry of Health of the Russian Federation
(Journal of Tuberculosis and Lung Diseases)
Processing of personal data
